Literature DB >> 22818162

Passing the baton: the HIF switch.

Mei Yee Koh1, Garth Powis.   

Abstract

Hypoxia is an inadequate oxygen supply to tissues and cells, which can restrict their function. The hypoxic response is primarily mediated by the hypoxia-inducible transcription factors, HIF-1 and HIF-2, which have both overlapping and unique target genes. HIF target gene activation is highly context specific and is not a reliable indicator of which HIF-α isoform is active. For example, in some cell lines, the individual HIFs have specific temporal and functional roles: HIF-1 drives the initial response to hypoxia (<24h) and HIF-2 drives the chronic response (>24h). Here, we review the significance of the HIF switch and the relation between HIF-1 and HIF-2 under both physiological and pathophysiological conditions.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22818162      PMCID: PMC3433036          DOI: 10.1016/j.tibs.2012.06.004

Source DB:  PubMed          Journal:  Trends Biochem Sci        ISSN: 0968-0004            Impact factor:   13.807


  82 in total

1.  ETS-1 converts endothelial cells to the angiogenic phenotype by inducing the expression of matrix metalloproteinases and integrin beta3.

Authors:  N Oda; M Abe; Y Sato
Journal:  J Cell Physiol       Date:  1999-02       Impact factor: 6.384

2.  HIF-1 alpha is required for solid tumor formation and embryonic vascularization.

Authors:  H E Ryan; J Lo; R S Johnson
Journal:  EMBO J       Date:  1998-06-01       Impact factor: 11.598

Review 3.  Molecular mechanisms of vasculogenesis and embryonic angiogenesis.

Authors:  I Flamme; T Frölich; W Risau
Journal:  J Cell Physiol       Date:  1997-11       Impact factor: 6.384

4.  Defective vascularization of HIF-1alpha-null embryos is not associated with VEGF deficiency but with mesenchymal cell death.

Authors:  L E Kotch; N V Iyer; E Laughner; G L Semenza
Journal:  Dev Biol       Date:  1999-05-15       Impact factor: 3.582

5.  Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1 alpha.

Authors:  N V Iyer; L E Kotch; F Agani; S W Leung; E Laughner; R H Wenger; M Gassmann; J D Gearhart; A M Lawler; A Y Yu; G L Semenza
Journal:  Genes Dev       Date:  1998-01-15       Impact factor: 11.361

6.  Endothelial PAS domain protein 1 (EPAS1), a transcription factor selectively expressed in endothelial cells.

Authors:  H Tian; S L McKnight; D W Russell
Journal:  Genes Dev       Date:  1997-01-01       Impact factor: 11.361

7.  Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium.

Authors:  G H Fong; J Rossant; M Gertsenstein; M L Breitman
Journal:  Nature       Date:  1995-07-06       Impact factor: 49.962

8.  Differential function of the prolyl hydroxylases PHD1, PHD2, and PHD3 in the regulation of hypoxia-inducible factor.

Authors:  Rebecca J Appelhoff; Ya-Min Tian; Raju R Raval; Helen Turley; Adrian L Harris; Christopher W Pugh; Peter J Ratcliffe; Jonathan M Gleadle
Journal:  J Biol Chem       Date:  2004-07-07       Impact factor: 5.157

9.  The hypoxia-responsive transcription factor EPAS1 is essential for catecholamine homeostasis and protection against heart failure during embryonic development.

Authors:  H Tian; R E Hammer; A M Matsumoto; D W Russell; S L McKnight
Journal:  Genes Dev       Date:  1998-11-01       Impact factor: 11.361

10.  Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension.

Authors:  G L Wang; B H Jiang; E A Rue; G L Semenza
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-06       Impact factor: 11.205

View more
  178 in total

1.  Mitochondrial respiratory chain composition and organization in response to changing oxygen levels.

Authors:  Alba Timón-Gómez; Antoni Barrientos
Journal:  J Life Sci (Westlake Village)       Date:  2020-06

Review 2.  To breathe or not to breathe: the haematopoietic stem/progenitor cells dilemma.

Authors:  C Piccoli; F Agriesti; R Scrima; F Falzetti; M Di Ianni; N Capitanio
Journal:  Br J Pharmacol       Date:  2013-08       Impact factor: 8.739

3.  Inhibition of monocarboxylate transporter 1 suppresses the proliferation of glioblastoma stem cells.

Authors:  Tetsuya Takada; Kazuyuki Takata; Eishi Ashihara
Journal:  J Physiol Sci       Date:  2016-02-22       Impact factor: 2.781

4.  Oxygen delivery from hyperbarically loaded microtanks extends cell viability in anoxic environments.

Authors:  Colin A Cook; Kathryn C Hahn; Justin B F Morrissette-McAlmon; Warren L Grayson
Journal:  Biomaterials       Date:  2015-03-03       Impact factor: 12.479

5.  [Expressions of OCT4, Notch1 and DLL4 and their clinical implications in epithelial ovarian cancer].

Authors:  Lan Yu; Yun-Jie Jiao; Lei Zhou; Wen-Qing Song; Shi-Wu Wu; Dan-Na Wang
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2016-04-20

Review 6.  Mitochondrial function at extreme high altitude.

Authors:  Andrew J Murray; James A Horscroft
Journal:  J Physiol       Date:  2015-06-26       Impact factor: 5.182

Review 7.  HIF Inhibitors: Status of Current Clinical Development.

Authors:  Jaleh Fallah; Brian I Rini
Journal:  Curr Oncol Rep       Date:  2019-01-22       Impact factor: 5.075

Review 8.  Current approaches and recent developments in the management of head and neck paragangliomas.

Authors:  David Taïeb; Alexandre Kaliski; Carsten C Boedeker; Victoria Martucci; Tito Fojo; John R Adler; Karel Pacak
Journal:  Endocr Rev       Date:  2014-07-17       Impact factor: 19.871

9.  O2-controllable hydrogels for studying cellular responses to hypoxic gradients in three dimensions in vitro and in vivo.

Authors:  Daniel M Lewis; Michael R Blatchley; Kyung Min Park; Sharon Gerecht
Journal:  Nat Protoc       Date:  2017-07-20       Impact factor: 13.491

10.  Hypoxia-Associated Factor (HAF) Mediates Neurofibromin Ubiquitination and Degradation Leading to Ras-ERK Pathway Activation in Hypoxia.

Authors:  Yangsook Song Green; Timothy Sargis; Ethan Conrad Reichert; Eleanor Rudasi; Daniel Fuja; Eric Jonasch; Mei Yee Koh
Journal:  Mol Cancer Res       Date:  2019-01-31       Impact factor: 5.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.